Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections

  • M. Friedemann


About 120–150 neonatal Cronobacter spp. (Enterobacter sakazakii) infections have been described. An analysis of current case numbers, epidemiological measures and risk factors is warranted. Data of microbiologically confirmed cases, published between 2000 and 2008, have been analysed statistically. More than 100 neonatal Cronobacter infections have been reported in this period. The overall lethality of the 67 invasive infections was 26.9%. The lethality of Cronobacter meningitis, bacteraemia and necrotising enterocolitis (NEC) was calculated to be 41.9% (P < 0.0001), <10% and 19.0% (P < 0.05), respectively. Logistic regression models (P < 0.0001) revealed a higher gestational age at birth and parentage not from Europe as significant factors for a higher reporting probability of neonatal Cronobacter meningitis. Neonates with Cronobacter meningitis not originating from North America have a higher risk for lethal outcome than other neonatal Cronobacter infections (P < 0.0001). Continental differences of risk factors for Cronobacter meningitis and for the lethal outcome of neonatal meningitis should be elucidated. Neonatal Cronobacter infections are mainly associated with the contamination of infant formula and of the relevant cleaning and preparation equipment. Eleven neonatal Cronobacter infections, not caused by contaminated infant formula, have been retrieved. Other environmental sources of infection should be considered. Consistent and sufficiently informative data of invasive neonatal Cronobacter infections should be recorded in a centralized reporting system.


Infant Formula Dermoid Cyst Neonatal Meningitis Powdered Infant Formula Intensive Medical Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Iversen C, Mullane N, McCardell B, Tall BD, Lehner A, Fanning S, Stephan R, Joosten H (2008) Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov. Int J Syst Evol Microbiol 58:1442–1447CrossRefPubMedGoogle Scholar
  2. 2.
    FAO/WHO (2006) Enterobacter sakazakii and Salmonella in powdered infant formula: meeting report. Available online at:
  3. 3.
    Mullane NR, Iversen C, Healy B, Walsh C, Whyte P, Wall PG, Quinn T, Fanning S (2007) Enterobacter sakazakii an emerging bacterial pathogen with implications for infant health. Minerva Pediatr 59:137–148PubMedGoogle Scholar
  4. 4.
    Lai KK (2001) Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore) 80:113–122CrossRefGoogle Scholar
  5. 5.
    Iversen C, Forsythe S (2003) Risk profile of Enterobacter sakazakii, an emergent pathogen associated with infant milk formula. Trends Food Sci Technol 14:443–454CrossRefGoogle Scholar
  6. 6.
    Gurtler JB, Kornacki JL, Beuchat LR (2005) Enterobacter sakazakii: a coliform of increased concern to infant health. Int J Food Microbiol 104:1–34CrossRefPubMedGoogle Scholar
  7. 7.
    Coignard B, Vaillant V, Vincent JP, Lefléche A, Mariani-Kurkdjan P, Bernet C, L´Héritaeau F, Sénénchal H, Grimont P, Bingen E, Desenclos JC (2006) Infections séverès à Enterobacter sakazakii chez des nouveau-nés ayant consommé une préparation en poudre pour nourissons, France, octubre-decembre 2004. Bulletin Epidemiologique Hebdomadaire 2–3:10–13Google Scholar
  8. 8.
    Himelright I, Harris E, Lorch V, Anderson M, Jones T, Craig A, Kuehnert M, Forster T, Arduino M, Jensen B, Jernigan D (2002) Enterobacter sakazakii infections associated with the use of powdered infant formula—Tennessee, 2001. J Am Med Assoc 287:2204–2205CrossRefGoogle Scholar
  9. 9.
    van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S (2001) Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol 39:293–297CrossRefPubMedGoogle Scholar
  10. 10.
    Noriega FR, Kotloff KL, Martin MA, Schwalbe RS (1990) Nosocomial bacteremia caused by Enterobacter sakazakii and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula. Pediatr Infect Dis J 9:447–449PubMedGoogle Scholar
  11. 11.
    Marcos M, Iñurrieta A, Soriano A, Martínez JA, Almela M, Marco F, Mensa J (2008) Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. J Antimicrob Chemother 62:397–403CrossRefPubMedGoogle Scholar
  12. 12.
    Patzer JA, Dzierzanowska D, Turner PJ (2008) Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997–2007). J Antimicrob Chemother 62:369–375CrossRefPubMedGoogle Scholar
  13. 13.
    Kim JB, Cho SH, Park YB, Lee JB, Kim JC, Lee BK, Lee HK, Chae HS (2008) Surveillance of stool samples for the presence of Enterobacter sakazakii among Korean people. Yonsei Med J 49:1017–1022CrossRefPubMedGoogle Scholar
  14. 14.
    FAO/WHO (2008) Enterobacter sakazakii (Cronobacter spp.) in powdered follow-up formulae: meeting report. Available online at:
  15. 15.
    Stoll BJ, Hansen N, Fanaroff AA, Lemons JA (2004) Enterobacter sakazakii is a rare cause of neonatal septicemia or meningitis in VLBW infants. J Pediatr 144:821–823PubMedGoogle Scholar
  16. 16.
    Friedemann M (2008) Enterobacter sakazakii in powdered infant formula. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:664–674CrossRefPubMedGoogle Scholar
  17. 17.
    Palcich G, deMorales-Gillio M, Aragon-Alegro LC, Pagotto FJ, Farber JM, Landgraf M, Destro MT (2009) Enterobacter sakazakii in dried infant formulas and milk kitchens of maternity wards in São Paulo, Brazil. J Food Prot 72:37–42PubMedGoogle Scholar
  18. 18.
    Gutierrez-Rojo R, Torres-Chavolla E (2007) A rapid polymerase chain reaction assay for Enterobacter sakazakii detection in infant milk formulas. J Rapid Methods Autom Microbiol 15:345–358CrossRefGoogle Scholar
  19. 19.
    Estuningsih S, Kress C, Hassan AA, Akineden O, Schneider E, Usleber E (2006) Enterobacteriaceae in dehydrated powdered infant formula manufactured in Indonesia and Malaysia. J Food Prot 69:3013–3017PubMedGoogle Scholar
  20. 20.
    Muytjens HL, Roelofs-Willemse H, Jaspar GH (1988) Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae. J Clin Microbiol 26:743–746PubMedGoogle Scholar
  21. 21.
    Ray P, Das A, Gautam V, Jain N, Narang A, Sharma M (2007) Enterobacter sakazakii in infants: novel phenomenon in India. Indian J Med Microbiol 25:408–410CrossRefPubMedGoogle Scholar
  22. 22.
    Barreira ER, Costa de Souza D, de Freitas Góis P, Fernandes JC (2003) Meningite por Enterobacter sakazakii em recém-nascido: relato de caso. Pediatria (São Paulo) 25:65–70Google Scholar
  23. 23.
    Bar-Oz B, Preminger A, Peleg O, Block C, Arad I (2001) Enterobacter sakazakii infection in the newborn. Acta Paediatr 90:356–358CrossRefPubMedGoogle Scholar
  24. 24.
    Tekkök IH, Higgins MJ, Ventureyra ECG, Baeesa SS (1996) Abscedation of posterior fossa dermoid cysts. Childs Nerv Syst 12:318–322CrossRefPubMedGoogle Scholar
  25. 25.
    Arseni A, Malamou-Ladas E, Koutsia C, Xanthou M, Trikka E (1987) Outbreak of colonization of neonates with Enterobacter sakazakii. J Hosp Infect 9:143–150CrossRefPubMedGoogle Scholar
  26. 26.
    Gosney MA, Martin MV, Wright AE, Gallagher M (2006) Enterobacter sakazakii in the mouths of stroke patients and its association with aspiration pneumonia. Eur J Intern Med 17:185–188CrossRefPubMedGoogle Scholar
  27. 27.
    See KC, Than HA, Tang T (2007) Enterobacter sakazakii bacteraemia with multiple splenic abscesses in a 75-year-old woman: a case report. Age Ageing 36:595–596CrossRefPubMedGoogle Scholar
  28. 28.
    Bowen AB, Braden CR (2006) Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis 12:1185–1189PubMedGoogle Scholar
  29. 29.
    Amsler KM, Davies TA, Shang W, Jacobs MR, Bush K (2008) In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections. Antimicrob Agents Chemother 52:3418–3423CrossRefPubMedGoogle Scholar
  30. 30.
    Thiesemann R, Walter EU, Füsgen I (2009) Nosocomial urinary tract infections in the geriatric hospital–pathogen spectrum and resistancies. Z Gerontol Geriatr 42:99–107CrossRefPubMedGoogle Scholar
  31. 31.
    European Commission (EC) (2005) Commission Regulation (EC) No. 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. Available online:
  32. 32.
    Lichtsinn H, Pritzer M, Hoffler U (1989) A nosocomial outbreak of neonatal infections due to multiple resistant Enterobacter sakazakii. Hygiene + Medizin 14:407–410Google Scholar
  33. 33.
    FAO/WHO (2008) Call for data: Enterobacter sakazakii in follow-up formulae. Available online at:
  34. 34.
    MOH (2005) E. sakazakii meningitis to become a notifiable disease. Available online at:
  35. 35.
    CDR (1993) Bacteraemia and bacterial meningitis. CDR Wkly 3:1Google Scholar
  36. 36.
    Health Canada (2002) Health professional advisory. Enterobacter sakazakii infection and powdered infant formulas. Available online at:
  37. 37.
    Suijkerbuijk AWM (2005) Gesignaleerd. Infectieziekten Bulletin 16:1–3Google Scholar
  38. 38.
    Coignard B, Poujol I, Carbonne A, Bernet C, Sénéchal H, Dumartin C, Raclot I, Lepoutre A, Thiolet JM, Bouraoui L, Descenclos JC (2006) Le signalement des infections nosocomiales, France, 2001–2005. Bulletin Épidemiologique Hebdomadaire 51–52:406–410Google Scholar
  39. 39.
    NOIS (2007) Norsk overvåkingssystem for infeksjoner i sykehustjenesten - registerforskriften: Kodeliste over mikroorganismer. Available online at:
  40. 40.
    CDR (2004) Bacteraemia 2003 England and Wales and Northern Ireland. Available online at:
  41. 41.
    RASFF (2009) Weekly notifications 8/2009. Available online at:
  42. 42.
    EWRS (2004) Early warning and response system. Home page at:
  43. 43.
    Muytjens HL, Zanen HC, Sonderkamp HJ, Kollée LA, Wachsmuth IK, Farmer JJ 3rd (1983) Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 18:115–120PubMedGoogle Scholar
  44. 44.
    Clark NC, Hill BC, O’Hara CM, Steingrimsson O, Cooksey RC (1990) Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks. Diagn Microbiol Infect Dis 13:467–472CrossRefPubMedGoogle Scholar
  45. 45.
    Nazarowec-White M, Farber JM (1997) Enterobacter sakazakii: a review. Int J Food Microbiol 34:103–113CrossRefPubMedGoogle Scholar
  46. 46.
    Codex Alimentarius Commission (CAC) (2008) Code of hygienic practice for powdered formulae for infants and young children. Home page at:
  47. 47.
    European Commission (EC) (2007) Commission Regulation (EC) No 1441/2007 of 5 December 2007 amending Regulation No 2073/2005 on microbiological criteria for foodstuffs. Available online at:
  48. 48.
    Muytjens HL, Kollée LA (1982) Neonatal meningitis due to Enterobacter sakazakii. Tijdschr Kindergeneeskd 50:110–112PubMedGoogle Scholar
  49. 49.
    Farmer JJ 3rd, Asbury MA, Hickman FW, Brenner DJ (1980) Enterobacter sakazakii: a new species of “Enterobacteriaceae” isolated from clinical specimens. Int J Syst Bacteriol 30:569–584CrossRefGoogle Scholar
  50. 50.
    Caubilla-Barron J, Hurrell E, Townsend S, Cheetham P, Loc-Carrillo C, Fayet O, Prère MF, Forsythe SJ (2007) Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France. J Clin Microbiol 45:3979–3985CrossRefPubMedGoogle Scholar
  51. 51.
    Burdette JH, Santos C (2000) Enterobacter sakazakii brain abscess in the neonate: the importance of neuroradiologic imaging. Pediatr Radiol 30:33–34CrossRefPubMedGoogle Scholar
  52. 52.
    RASFF (2002) Alert notification 2002/190: Enterobacter sakazakii in infant formulae from Germany. Available online at:
  53. 53.
    Jarvis C (2005) Fatal Enterobacter sakazakii infection associated with powdered infant formula in a neonatal intensive care unit in New Zealand. Am J Infect Control 33:E19CrossRefGoogle Scholar
  54. 54.
    RASFF (2004) Alert notification 2004/658: Enterobacter sakazakii in infant formula. Available online at:
  55. 55.
    Pavcnik-Arnol M, Hojker S, Derganc M (2007) Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 33:1025–1032CrossRefPubMedGoogle Scholar
  56. 56.
    Aguirre-Conde A, Pérez-Legorburu A, Echániz-Urcelay I, Hernando-Zaráte Z, Arrate-Zugazabeitia JK (2007) Sepsis neonatal por Enterobacter sakazakii. An Pediatr (Barc) 66:196–197CrossRefGoogle Scholar
  57. 57.
    Mange JP, Stephan R, Borel N, Wild P, Kim KS, Pospischil A, Lehner A (2006) Adhesive properties of Enterobacter sakazakii to human epithelial and brain microvascular endothelial cells. BMC Microbiol 6:58CrossRefPubMedGoogle Scholar
  58. 58.
    Major P (2006) Rapid method for detection of DNAse activity of Enterobacter sakazakii. Available online at:
  59. 59.
    RASFF (2007) Alert notification 2007/452: Enterobacter sakazakii (present/10 g) in infant formula from Switzerland via Germany. Available online at:
  60. 60.
    Marler B, Clark B (2008) New Mexican baby death blamed on Enterobacter sakazakii. Available online at:

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Federal Institute for Risk Assessment (BfR)BerlinGermany

Personalised recommendations